These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 14067358)
1. THE INFLUENCE OF A AND B BLOOD GROUP SUBSTANCES ON THE 7S FRACTIONS OF ANTI-A AND ANTI-B. HOSTRUP H Vox Sang; 1963; 8():567-82. PubMed ID: 14067358 [No Abstract] [Full Text] [Related]
3. COMPLEMENT FIXING ANTIBODIES IN RELATION TO HEMOLYTIC DISEASE OF THE NEWBORN. STRATTON F; GUNSON HH; RAWLINSON VI Transfusion; 1965; 5():216-22. PubMed ID: 14293261 [No Abstract] [Full Text] [Related]
4. OBSERVATIONS ON THE SPECIFICITY OF ANTI-O AND ANTI-A1 SERA. GOLD ER Vox Sang; 1964; 9():153-9. PubMed ID: 14147431 [No Abstract] [Full Text] [Related]
5. RH FACTOR. INTRODUCTION: HEMOLYTIC DISEASE OF THE NEWBORN. BANNER EA Clin Obstet Gynecol; 1964 Dec; 10():906-15. PubMed ID: 14234043 [No Abstract] [Full Text] [Related]
7. ABO HEMOLYTIC DISEASE OF THE NEWBORN: A FAMILY STUDY WITH EMPHASIS ON THE STRENGTH OF THE A ANTIGEN. GRUNDBACHER FJ Pediatrics; 1965 Jun; 35():916-24. PubMed ID: 14296417 [No Abstract] [Full Text] [Related]
8. [Haemolytic disease of the newborn (fetus) (author's transl)]. Fischer K; Poschmann A Immun Infekt; 1976 Dec; 4(6):249-60. PubMed ID: 828142 [TBL] [Abstract][Full Text] [Related]
9. A AND B BLOOD GROUP SUBSTANCES IN THE SERUM OF THE NEWBORN INFANT AND THE FOETUS. HOSTRUP H Vox Sang; 1963; 8():557-66. PubMed ID: 14067357 [No Abstract] [Full Text] [Related]
10. Prenatal and perinatal immunohematology: recommendations for serologic management of the fetus, newborn infant, and obstetric patient. Judd WJ; Luban NL; Ness PM; Silberstein LE; Stroup M; Widmann FK Transfusion; 1990 Feb; 30(2):175-83. PubMed ID: 2154871 [No Abstract] [Full Text] [Related]
11. [Fetal erythroblastosis and the Kell blood group]. VAN LOGHEM JJ; DE RAAD H; VAN HATTEM A Maandschr Kindergeneeskd; 1953 Feb; 21(2):63-72. PubMed ID: 13053924 [No Abstract] [Full Text] [Related]
12. Fetal blood group determination in amniotic cells. Vázquez-Escobosa C; Pérez-Medina R; Ramos-Damián ME; Gómez-Estrada H Arch Invest Med (Mex); 1982; 13(2):101-4 passim. PubMed ID: 6808946 [No Abstract] [Full Text] [Related]
13. Placental permeability in the human for anti-A and anti-B isoantibodies. Clinical implications. FREDA VJ; CARTER BA Am J Obstet Gynecol; 1962 Nov; 84():1351-67. PubMed ID: 13959385 [No Abstract] [Full Text] [Related]
14. [Production of KU-ABO preparations in hospitals for the treatment of hemolytic disease of the newborn]. Cwik J; Dimmich H; Przudzik J Pediatr Pol; 1985 Sep; 60(9):658-61. PubMed ID: 3831899 [No Abstract] [Full Text] [Related]
15. Response to immunization with A and B human glycoproteins for the procurement of blood grouping reagents. Contreras M; Armitage SE; Hewitt PE Vox Sang; 1984; 47(3):224-35. PubMed ID: 6464421 [TBL] [Abstract][Full Text] [Related]
16. [Physiopathology of Rh-prevention. Elimination of rhesus-positive radio-chromium labeled umbilical cord erythrocytes in rhesus-negative persons after application of anti-D-serums]. Schneider J; Leidenberger H; Heimpel H Med Klin; 1970 Apr; 65(15):718-23. PubMed ID: 4108360 [No Abstract] [Full Text] [Related]
17. ABO ERYTHROBLASTOSIS; A CASE REPORT. SHETH SC; MEHTA KA Indian J Child Health; 1963 Dec; 12():812-4. PubMed ID: 14097527 [No Abstract] [Full Text] [Related]
18. [Diego blood system and the antibodies]. Tsuneyama H Nihon Rinsho; 2005 Jul; 63 Suppl 7():692-4. PubMed ID: 16111370 [No Abstract] [Full Text] [Related]
19. [COMBINED RH AND ABO ERYTHROBLASTOSIS IN THE NEWBORN]. LUEDERS D Monatsschr Kinderheilkd (1902); 1964 Sep; 112():407-15. PubMed ID: 14316372 [No Abstract] [Full Text] [Related]